// App-Quantinova.ai

208 : Microvascular flow assessed by dynamic optical coherence tomography: first non-invasive quantitative outcome measure of microvascular disease in systemic sclerosis

Researchers

Presenter

  • Giuseppina Abignano

Principal Investigators

  • Alexandra Daniel

  • Lorraine Green

  • Sookhoe Eng

  • Paul Emery

  • Francesco Del Galdo

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR BRC, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, UNITED KINGDOM

  • Rheumatology Institute of Lucania (IReL), Rheumatology Department of Lucania, Potenza, Italy

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Raynaud syndrome

  • Scleroderma

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A